Enanta Pharmaceuticals | Creditori Commerciali





Creditori Commerciali Cambiamento Data
AbbVie USD 32.25B 1.2B 2025-06
Amgen USD 20.89B 1.25B 2025-12
Anika Therapeutics USD 4.73M 39K 2025-09
Arrowhead Research USD 32.94M 15.26M 2025-12
AstraZeneca USD 25.03B 1.04B 2025-09
BioCryst Pharmaceuticals USD 5.57M 3.02M 2025-09
Biogen USD 432M 18.9M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Enanta Pharmaceuticals USD 1.95M 1.6M 2025-09
Gilead Sciences USD 808M 226M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Halozyme Therapeutics USD 15.36M 3.33M 2025-09
Heron Therapeutics USD 12.02M 20K 2025-09
Immunic USD 7.92M 25K 2025-09
Incyte USD 1.63B 1.46B 2025-12
Insmed USD 79.59M 1.24M 2025-09
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
J&J USD 9.62B 161M 2025-09
Karyopharm Therapeutics USD 5.39M 2.8M 2025-09
Ligand Pharmaceuticals USD 27.76M 1.72M 2025-09
Merck USD 4.15B 102M 2025-09
Neurocrine Biosciences USD 119.9M 15.3M 2025-09
Novartis USD 4.56B 49M 2025-09
Novavax USD 15.23M 35.37M 2025-09
Pfizer USD 5.02B 142M 2025-09
PTC Therapeutics USD 36.62M 169.69M 2025-09
Roche Holding CHF 5.78B 1.27B 2025-12
Sarepta Therapeutics USD 94.02M 42.69M 2025-09
Vertex Pharmaceuticals USD 4.03B 320.8M 2025-09


Enanta Pharmaceuticals Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.